UK markets closed

CellSource Co., Ltd. (4880.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
1,344.00+9.00 (+0.67%)
At close: 03:15PM JST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/10/2023
31/10/2022
31/10/2021
31/10/2020
Total revenue
4,273,829
4,510,544
4,273,829
2,922,232
1,855,475
Cost of revenue
1,209,528
1,325,543
1,209,528
848,207
596,519
Gross profit
3,064,300
3,185,000
3,064,300
2,074,025
1,258,956
Operating expenses
Research development
87,562
72,453
87,562
71,161
10,817
Selling general and administrative
425,481
557,750
425,481
298,728
292,740
Total operating expenses
1,493,243
1,963,497
1,493,243
1,081,579
843,401
Operating income or loss
1,571,057
1,221,503
1,571,057
992,446
415,555
Interest expense
11
379
11
136
286
Income before tax
1,583,639
1,239,682
1,583,639
1,006,367
412,807
Income tax expense
565,796
316,540
565,796
354,971
138,725
Income from continuing operations
1,017,843
923,142
1,017,843
651,396
274,082
Net income
1,017,842
923,142
1,017,842
651,396
274,082
Net income available to common shareholders
1,017,842
923,142
1,017,842
651,396
274,082
Basic EPS
58.95
48.88
54.54
35.17
15.19
Diluted EPS
57.45
47.93
52.98
33.91
14.33
Basic average shares
18,739
18,884
18,662
18,521
18,049
Diluted average shares
19,215
19,260
19,212
19,210
19,126